Evidence map›Paper›PMID 17660276›Full record

ArticleRNA (New York, N.Y.)2007

Genetic analysis of the E site during RF2 programmed frameshifting.

Christina L Sanders, James F Curran

Erratum issuedAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. In vivo selection of synthetic nucleocapsids for tissue targeting.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Ribosome collisions alter frameshifting at translational reprogramming motifs in bacterial mRNAs.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Frameshifting dynamics.Biopolymers · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cellular mechanisms that control mistranslation.Nature reviews. Microbiology · 2010
    Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors.

Christina L SandersDepartment of Biology, Wake Forest University, Winston-Salem, NC 27106, USA.
James F Curran

Funding

Does the ribosomal E site help hold the reading frame?R15GM077194 · NIGMS · WAKE FOREST UNIVERSITY · PI CURRAN, JAMES F. · 2006 to 2009
$414k
NIGMS NIH HHS GM077194NIGMS NIH HHS R15 GM077194
6 · The paper itself

Abstract

The roles of the ribosomal E site are not fully understood. Prior evidence suggests that deacyl-tRNA in the E site can prevent frameshifting. We hypothesized that if the E-site codon must dissociate from its tRNA to allow for frameshifting, then weak codon:anticodon duplexes should allow for greater frameshifting than stronger duplexes. Using the well-characterized Escherichia coli RF2 (prfB) programmed frameshift to study frameshifting, we mutagenized the E-site triplet to all Unn and Cnn codons. Those variants should represent a very wide range of duplex stability. Duplex stability was estimated using two different methods. Frameshifting is inversely correlated with stability, as estimated by either method. These findings indicate that pairing between the deacyl-tRNA and the E-site codon opposes frameshifting. We discuss the implications of these findings on frame maintenance and on the RF2 programmed frameshift mechanism.

Indexed as

AnticodonCodonEscherichia coliEscherichia coli ProteinsFrameshift MutationNucleic Acid HeteroduplexesPeptide Termination FactorsProtein BiosynthesisReading FramesRibosomesAnticodonCodonEscherichia coli ProteinsNucleic Acid HeteroduplexesPeptide Termination FactorsprfB protein, E coli

Identifiers

PMID17660276
PMCPMC1950767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.